Reprogramming and carcinogenesis-parallels and distinctions

International Review of Cell and Molecular Biology

Volumn 308, Issue , 2014, Pages 167-203

  Wasik, Agata M ^a   Grabarek, Jerzy ^b   Pantovic, Aleksandar ^c   Cieślar Pobuda, Artur ^d,e   Asgari, Hamid R ^f   Bundgaard Nielsen, Caspar ^d,g   Rafat, Mehrdad ^d   Dixon, Ian M C ^h   Ghavami, Saeid ^h   Łos, Marek J ^b,d,i  

^a KAROLINSKA UNIVERSITY HOSPITAL   (Sweden)

^b POMERANIAN MEDICAL UNIVERSITY   (Poland)

^c UNIVERSITY OF BELGRADE   (Serbia)

^d LINKÖPING UNIVERSITY   (Sweden)

^e SILESIAN UNIVERSITY OF TECHNOLOGY   (Poland)

^f TEHRAN UNIVERSITY OF MEDICAL SCIENCES   (Iran)

^g AALBORG UNIVERSITY   (Denmark)

^h UNIVERSITY OF MANITOBA   (Canada)

ⁱ BioApplications Enterprises Winnipeg   (Canada)

Author keywords

Bioglass; IPS cells; P53; Senescence; Transdifferentiation; Yamanaka factor

Indexed keywords

BIOMATERIAL; TRANSCRIPTION FACTOR;

ANTIPROLIFERATIVE ACTIVITY; APOPTOSIS; ARTICLE; AUTOPHAGY; CANCER STEM CELL; CARCINOGENESIS; CELL DIFFERENTIATION; HUMAN; NONHUMAN; NUCLEAR REPROGRAMMING; PLURIPOTENT STEM CELL; PRIORITY JOURNAL; SENESCENCE; STEM CELL; TUMOR SUPPRESSOR GENE; ANIMAL; CYTOLOGY; PATHOLOGY;

ANIMALS; CARCINOGENESIS; CELLULAR REPROGRAMMING; HUMANS; INDUCED PLURIPOTENT STEM CELLS;

EID: 84892176061     PISSN: 19376448     EISSN: None     Source Type: Book Series    
DOI: 10.1016/B978-0-12-800097-7.00005-1     Document Type: Chapter

References (184)

1. Abounit K., Scarabelli T.M., McCauley R.B. Autophagy in mammalian cells. World J. Biol. Chem. 2012, 3:1-6.
2. Armstrong L., Tilgner K., Saretzki G., Atkinson S.P., Stojkovic M., Moreno R., Przyborski S., Lako M. Human induced pluripotent stem cell lines show stress defense mechanisms and mitochondrial regulation similar to those of human embryonic stem cells. Stem Cells 2010, 28:661-673.
3. Auernheimer J., Zukowski D., Dahmen C., Kantlehehner M., Enderle A., Goodman S.L., Kessler H. Titanium implant materials with improved biocompatibility through coating with phosphonate-anchored cyclic RGD peptides. ChemBioChem 2005, 6:2034-2040.
4. Bae D., Mondragon-Teran P., Hernandez D., Ruban L., Mason C., Bhattacharya S.S., Veraitch F.S. Hypoxia enhances the generation of retinal progenitor cells from human induced pluripotent and embryonic stem cells. Stem Cells Dev. 2012, 21:1344-1355.
5. Banito A., Gil J. Induced pluripotent stem cells and senescence: learning the biology to improve the technology. EMBO Rep. 2010, 11:353-359.
6. Banito A., Rashid S.T., Acosta J.C., Li S., Pereira C.F., Geti I., Pinho S., Silva J.C., Azuara V., Walsh M., Vallier L., Gil J. Senescence impairs successful reprogramming to pluripotent stem cells. Genes Dev. 2009, 23:2134-2139.
7. Bao S., Wu Q., McLendon R.E., Hao Y., Shi Q., Hjelmeland A.B., Dewhirst M.W., Bigner D.D., Rich J.N. Glioma stem cells promote radioresistance by preferential activation of the DNA damage response. Nature 2006, 444:756-760.
8. Bass A.J., Watanabe H., Mermel C.H., Yu S., Perner S., Verhaak R.G., Kim S.Y., Wardwell L., Tamayo P., Gat-Viks I., Ramos A.H., Woo M.S., Weir B.A., Getz G., Beroukhim R., O'Kelly M., Dutt A., Rozenblatt-Rosen O., Dziunycz P., Komisarof J., Chirieac L.R., Lafargue C.J., Scheble V., Wilbertz T., Ma C., Rao S., Nakagawa H., Stairs D.B., Lin L., Giordano T.J., Wagner P., Minna J.D., Gazdar A.F., Zhu C.Q., Brose M.S., Cecconello I., Jr U.R., Marie S.K., Dahl O., Shivdasani R.A., Tsao M.S., Rubin M.A., Wong K.K., Regev A., Hahn W.C., Beer D.G., Rustgi A.K., Meyerson M. SOX2 is an amplified lineage-survival oncogene in lung and esophageal squamous cell carcinomas. Nat. Genet. 2009, 41:1238-1242.
9. Basu-Roy U., Seo E., Ramanathapuram L., Rapp T.B., Perry J.A., Orkin S.H., Mansukhani A., Basilico C. Sox2 maintains self renewal of tumor-initiating cells in osteosarcomas. Oncogene 2012, 31:2270-2282.
10. Beier D., Wischhusen J., Dietmaier W., Hau P., Proescholdt M., Brawanski A., Bogdahn U., Beier C.P. CD133 expression and cancer stem cells predict prognosis in high-grade oligodendroglial tumors. Brain Pathol. 2008, 18:370-377.
11. Ben-Porath I., Thomson M.W., Carey V.J., Ge R., Bell G.W., Regev A., Weinberg R.A. An embryonic stem cell-like gene expression signature in poorly differentiated aggressive human tumors. Nat. Genet. 2008, 40:499-507.
12. Binyamin G., Shafi B., Mery C. Biomaterials: a primer for surgeons. Semin. Paediatr. Surg. 2006, 15:276-283.
13. Bitarte N., Bandres E., Boni V., Zarate R., Rodriguez J., Gonzalez-Huarriz M., Lopez I., Javier Sola J., Alonso M.M., Fortes P., Garcia-Foncillas J. MicroRNA-451 is involved in the self-renewal, tumorigenicity, and chemoresistance of colorectal cancer stem cells. Stem Cells 2011, 29:1661-1671.
14. Booth H.A., Holland P.W. Eleven daughters of NANOG. Genomics 2004, 84:229-238.
15. Brand K.G. Do implanted medical devices cause cancerα. J. Biomater. Appl. 1994, 8:325-343.
16. Cantz T., Key G., Bleidissel M., Gentile L., Han D.W., Brenne A., Scholer H.R. Absence of OCT4 expression in somatic tumor cell lines. Stem Cells 2008, 26:692-697.
17. Cao D., Liu A., Wang F., Allan R.W., Mei K., Peng Y., Du J., Guo S., Abel T.W., Lane Z., Ma J., Rodriguez M., Akhi S., Dehiya N., Li J. RNA-binding protein LIN28 is a marker for primary extragonadal germ cell tumors: an immunohistochemical study of 131 cases. Mod. Pathol. 2011, 24:288-296.
18. Case C.P., Langkamer V.G., James C., Palmer M.R., Kemp A.J., Heap P.F., Solomon L. Widespread Dissemination of Metal Debris from Implants. J. Bone Joint Surg. 1994, 76-B:701-712.
19. Chappell J., Dalton S. Altered cell cycle regulation helps stem-like carcinoma cells resist apoptosis. BMC Biol. 2010, 8:63.
20. Chen Y.J., Wu C.Y., Chang C.C., Ma C.J., Li M.C., Chen C.M. Nuclear Kruppel-like factor 4 expression is associated with human skin squamous cell carcinoma progression and metastasis. Cancer Biol. Ther. 2008, 7:777-782.
21. Chen T., Shen L., Yu J., Wan H., Guo A., Chen J., Long Y., Zhao J., Pei G. Rapamycin and other longevity-promoting compounds enhance the generation of mouse induced pluripotent stem cells. Aging Cell 2011, 10:908-911.
22. Chen S., Xu Y., Chen Y., Li X., Mou W., Wang L., Liu Y., Reisfeld R.A., Xiang R., Lv D., Li N. SOX2 gene regulates the transcriptional network of oncogenes and affects tumorigenesis of human lung cancer cells. PLoS One 2012, 7:e36326.
23. Chiou S.H., Yu C.C., Huang C.Y., Lin S.C., Liu C.J., Tsai T.H., Chou S.H., Chien C.S., Ku H.H., Lo J.F. Positive correlations of Oct-4 and Nanog in oral cancer stem-like cells and high-grade oral squamous cell carcinoma. Clin. Cancer Res. 2008, 14:4085-4095.
24. Chylicki K., Ehinger M., Svedberg H., Gullberg U. Characterization of the molecular mechanisms for p53-mediated differentiation. Cell Growth Differ. 2000, 11:561-571.
25. Cobaleda C. Reprogramming of B cells. Methods Mol. Biol. 2010, 636:233-250.
26. de Cremoux P., Salomon A.V., Liva S., Dendale R., Bouchind'homme B., Martin E., Sastre-Garau X., Magdelenat H., Fourquet A., Soussi T. p53 mutation as a genetic trait of typical medullary breast carcinoma. J. Natl. Cancer Inst. 1999, 91:641-643.
27. Denishefsky I., Oppenheimer E.T., Heritier-Watkins O., Bella A., Willhite M. Biochemical changes in the connective tissue pocket surrounding subcutaeously imbedded films. Cancer Res. 1967, 27:833-837.
28. Dickinson L.E., Kusuma S., Gerecht S. Reconstructing the differentiation niche of embryonic stem cells using biomaterials. Macromol. Rapid Commun. 2011, 11:36-49.
29. Doi A., Park I.H., Wen B., Murakami P., Aryee M.J., Irizarry R., Herb B., Ladd-Acosta C., Rho J., Loewer S., Miller J., Schlaeger T., Daley G.Q., Feinberg A.P. Differential methylation of tissue- and cancer-specific CpG island shores distinguishes human induced pluripotent stem cells, embryonic stem cells and fibroblasts. Nat. Genet. 2009, 41:1350-1353.
30. Eberhard D., Jockusch H. Clonal and territorial development of the pancreas as revealed by eGFP-labelled mouse chimeras. Cell Tissue Res. 2010, 342:31-38.
31. Egler R.A., Fernandes E., Rothermund K., Sereika S., de Souza-Pinto N., Jaruga P., Dizdaroglu M., Prochownik E.V. Regulation of reactive oxygen species, DNA damage, and c-Myc function by peroxiredoxin 1. Oncogene 2005, 24:8038-8050.
32. Eshghi S., Schaffer D.V. Engineering microenviroments to control stem cell fate and function. StemBook 2008, 1-12.
33. Esteban M.A., Wang T., Qin B., Yang J., Qin D., Cai J., Li W., Weng Z., Chen J., Ni S., Chen K., Li Y., Liu X., Xu J., Zhang S., Li F., He W., Labuda K., Song Y., Peterbauer A., Wolbank S., Redl H., Zhong M., Cai D., Zeng L., Pei D. Vitamin C enhances the generation of mouse and human induced pluripotent stem cells. Cell Stem Cell 2010, 6:71-79.
34. Evans P.M., Liu C. Roles of Krupel-like factor 4 in normal homeostasis, cancer and stem cells. Acta Biochim. Biophys. Sin. (Shanghai) 2008, 40:554-564.
35. Fagin J.A., Matsuo K., Karmakar A., Chen D.L., Tang S.H., Koeffler H.P. High prevalence of mutations of the p53 gene in poorly differentiated human thyroid carcinomas. J. Clin. Invest. 1993, 91:179-184.
36. Feinstein E., Gale R.P., Reed J., Canaani E. Expression of the normal p53 gene induces differentiation of K562 cells. Oncogene 1992, 7:1853-1857.
37. Feng Q., Lu S.J., Klimanskaya I., Gomes I., Kim D., Chung Y., Honig G.R., Kim K.S., Lanza R. Hemangioblastic derivatives from human induced pluripotent stem cells exhibit limited expansion and early senescence. Stem Cells 2010, 28:704-712.
38. Feng C., Neumeister V., Ma W., Xu J., Lu L., Bordeaux J., Maihle N.J., Rimm D.L., Huang Y. Lin28 regulates HER2 and promotes malignancy through multiple mechanisms. Cell Cycle (Georgetown, Tex.) 2012, 11:2486-2494.
39. Fimia G.M., Stoykova A., Romagnoli A., Giunta L., Di Bartolomeo S., Nardacci R., Corazzari M., Fuoco C., Ucar A., Schwartz P., Gruss P., Piacentini M., Chowdhury K., Cecconi F. Ambra1 regulates autophagy and development of the nervous system. Nature 2007, 447:1121-1125.
40. Fusaki N., Ban H., Nishiyama A., Saeki K., Hasegawa M. Efficient induction of transgene-free human pluripotent stem cells using a vector based on Sendai virus, an RNA virus that does not integrate into the host genome. Proc. Jpn. Acad., Ser. B, Phys. Biol. Sci. 2009, 85:348-362.
41. Galli R., Binda E., Orfanelli U., Cipelletti B., Gritti A., De Vitis S., Fiocco R., Foroni C., Dimeco F., Vescovi A. Isolation and characterization of tumorigenic, stem-like neural precursors from human glioblastoma. Cancer Res. 2004, 64:7011-7021.
42. Ghavami S., Eshragi M., Ande S.R., Chazin W.J., Klonisch T., Halayko A.J., McNeill K.D., Hashemi M., Kerkhoff C., Los M. S100A8/A9 induces autophagy and apoptosis via ROS-mediated cross-talk between mitochondria and lysosomes that involves BNIP3. Cell Res. 2010, 20:314-331.
43. Ghavami S., Mutawe M.M., Sharma P., Yeganeh B., McNeill K.D., Klonisch T., Unruh H., Kashani H.H., Schaafsma D., Los M., Halayko A.J. Mevalonate cascade regulation of airway mesenchymal cell autophagy and apoptosis: a dual role for p53. PLoS One 2011, 6:e16523.
44. Ghavami S., Cunnington R.H., Yeganeh B., Davies J.J., Rattan S.G., Bathe K., Kavosh M., Los M.J., Freed D.H., Klonisch T., Pierce G.N., Halayko A.J., Dixon I.M. Autophagy regulates trans fatty acid-mediated apoptosis in primary cardiac myofibroblasts. Biochim. Biophys. Acta 2012, 1823:2274-2286.
45. Ghavami S., Mutawe M.M., Schaafsma D., Yeganeh B., Unruh H., Klonisch T., Halayko A.J. Geranylgeranyl transferase 1 modulates autophagy and apoptosis in human airway smooth muscle. Am. J. Physiol. Lung Cell. Mol. Physiol. 2012, 302:L420-L428.
46. Ghule P.N., Medina R., Lengner C.J., Mandeville M., Qiao M., Dominski Z., Lian J.B., Stein J.L., van Wijnen A.J., Stein G.S. Reprogramming the pluripotent cell cycle: restoration of an abbreviated G1 phase in human induced pluripotent stem (iPS) cells. J. Cell. Physiol. 2011, 226:1149-1156.
47. Girouard S.D., Laga A.C., Mihm M.C., Scolyer R.A., Thompson J.F., Zhan Q., Widlund H.R., Lee C.W., Murphy G.F. SOX2 contributes to melanoma cell invasion. Lab. Invest. 2012, 92:362-370.
48. Godar S., Ince T.A., Bell G.W., Feldser D., Donaher J.L., Bergh J., Liu A., Miu K., Watnick R.S., Reinhardt F., McAllister S.S., Jacks T., Weinberg R.A. Growth-inhibitory and tumor-suppressive functions of p53 depend on its repression of CD44 expression. Cell 2008, 134:62-73.
49. Gore A., Li Z., Fung H.L., Young J.E., Agarwal S., Antosiewicz-Bourget J., Canto I., Giorgetti A., Israel M.A., Kiskinis E., Lee J.H., Loh Y.H., Manos P.D., Montserrat N., Panopoulos A.D., Ruiz S., Wilbert M.L., Yu J., Kirkness E.F., Izpisua Belmonte J.C., Rossi D.J., Thomson J.A., Eggan K., Daley G.Q., Goldstein L.S., Zhang K. Somatic coding mutations in human induced pluripotent stem cells. Nature 2011, 471:63-67.
50. Guo X., Tang Y. KLF4 translation level is associated with differentiation stage of different pediatric leukemias in both cell lines and primary samples. Clin. Exp. Med. 2012, 13:99-107.
51. Gustafsson A.B., Gottlieb R.A. Autophagy in ischemic heart disease. Circ. Res. 2009, 104:150-158.
52. Hanada T., Noda N.N., Satomi Y., Ichimura Y., Fujioka Y., Takao T., Inagaki F., Ohsumi Y. The Atg12-Atg5 conjugate has a novel E3-like activity for protein lipidation in autophagy. J. Biol. Chem. 2007, 282:37298-37302.
53. Hanley J., Rastegarlari G., Nathwani A.C. An introduction to induced pluripotent stem cells. Br. J. Haematol. 2010, 151:16-24.
54. Hanna J., Saha K., Pando B., van Zon J., Lengner C.J., Creyghton M.P., van Oudenaarden A., Jaenisch R. Direct cell reprogramming is a stochastic process amenable to acceleration. Nature 2009, 462:595-601.
55. Harper L.J., Costea D.E., Gammon L., Fazil B., Biddle A., Mackenzie I.C. Normal and malignant epithelial cells with stem-like properties have an extended G2 cell cycle phase that is associated with apoptotic resistance. BMC Cancer 2010, 10:166.
56. Hauff K., Zamzow C., Law W.J., De Melo J., Kennedy K., Los M. Peptide-based approaches to treat asthma, arthritis, other autoimmune diseases and pathologies of the central nervous system. Arch. Immunol. Ther. Exp. 2005, 53:308-320.
57. Hellebrekers D.M., Griffioen A.W., van Engeland M. Dual targeting of epigenetic therapy in cancer. Biochim. Biophys. Acta 2007, 1775:76-91.
58. Hench L. Biomaterials. Science 1980, 208:826-831.
59. Hench L., Thompson I. Twenty-first century challenges for biomaterials. J. R. Soc. Interface. 2010, 7:379-391.
60. Hench L., Wilson J. Surface-Active Biomaterials. Science 1984, 226:630-636.
61. Hockemeyer D., Soldner F., Cook E.G., Gao Q., Mitalipova M., Jaenisch R. A drug-inducible system for direct reprogramming of human somatic cells to pluripotency. Cell Stem Cell 2008, 3:346-353.
62. Hoffmeyer K., Raggioli A., Rudloff S., Anton R., Hierholzer A., Del Valle I., Hein K., Vogt R., Kemler R. Wnt/beta-catenin signaling regulates telomerase in stem cells and cancer cells. Science 2012, 336:1549-1554.
63. Hong H., Takahashi K., Ichisaka T., Aoi T., Kanagawa O., Nakagawa M., Okita K., Yamanaka S. Suppression of induced pluripotent stem cell generation by the p53-p21 pathway. Nature 2009, 460:1132-1135.
64. Hotta A., Ellis J. Retroviral vector silencing during iPS cell induction: an epigenetic beacon that signals distinct pluripotent states. J. Cell. Biochem. 2008, 105:940-948.
65. Hu X., Ghisolfi L., Keates A.C., Zhang J., Xiang S., Lee D.K., Li C.J. Induction of cancer cell stemness by chemotherapy. Cell Cycle (Georgetown, Tex.) 2012, 11:2691-2698.
66. Huang P., Qiu J., Li B., Hong J., Lu C., Wang L., Wang J., Hu Y., Jia W., Yuan Y. Role of Sox2 and Oct4 in predicting survival of hepatocellular carcinoma patients after hepatectomy. Clin. Biochem. 2011, 44:582-589.
67. Jain M.V., Paczulla A.M., Klonisch T., Dimgba F.N., Rao S.B., Roberg K., Schweizer F., Lengerke C., Davoodpour P., Palicharla V.R., Maddika S., Los M. Interconnections between apoptotic, autophagic and necrotic pathways: implications for cancer therapy development. J. Cell. Mol. Med. 2013, 17:12-29.
68. Jangamreddy J.R., Los M.J. Mitoptosis, a novel mitochondrial death mechanism leading predominantly to activation of autophagy. Hepat. Mon. 2012, 12:e6159.
69. Jangamreddy J.R., Ghavami S., Grabarek J., Kratz G., Wiechec E., Fredriksson B.A., Rao R.K., Cieślar-Pobuda A., Panigrahi S., Los M.J. Salinomycin induces activation of autophagy, mitophagy and affects mitochondrial polarity: differences between primary-, and cancer cells. Biochim. Biophys. Acta 2013, 1833:2057-2069. 10.1016/j.bbamcr.2013.04.011.
70. Jeter C.R., Badeaux M., Choy G., Chandra D., Patrawala L., Liu C., Calhoun-Davis T., Zaehres H., Daley G.Q., Tang D.G. Functional evidence that the self-renewal gene NANOG regulates human tumor development. Stem Cells 2009, 27:993-1005.
71. Jia F., Wilson K.D., Sun N., Gupta D.M., Huang M., Li Z., Panetta N.J., Chen Z.Y., Robbins R.C., Kay M.A., Longaker M.T., Wu J.C. A nonviral minicircle vector for deriving human iPS cells. Nat. Methods 2010, 7:197-199.
72. Jia W., Pua H.H., Li Q.J., He Y.W. Autophagy regulates endoplasmic reticulum homeostasis and calcium mobilization in T lymphocytes. J. Immunol. 2011, 186:1564-1574.
73. Jia X., Li X., Xu Y., Zhang S., Mou W., Liu Y., Lv D., Liu C.H., Tan X., Xiang R., Li N. SOX2 promotes tumorigenesis and increases the anti-apoptotic property of human prostate cancer cell. J. Mol. Cell Biol. 2011, 3:230-238.
74. Junttila M.R., Karnezis A.N., Garcia D., Madriles F., Kortlever R.M., Rostker F., Brown Swigart L., Pham D.M., Seo Y., Evan G.I., Martins C.P. Selective activation of p53-mediated tumour suppression in high-grade tumours. Nature 2010, 468:567-571.
75. Kaji K., Norrby K., Paca A., Mileikovsky M., Mohseni P., Woltjen K. Virus-free induction of pluripotency and subsequent excision of reprogramming factors. Nature 2009, 458:771-775.
76. Kang R., Zeh H.J., Lotze M.T., Tang D. The Beclin 1 network regulates autophagy and apoptosis. Cell Death Differ. 2011, 18:571-580.
77. Karimi-Busheri F., Rasouli-Nia A., Mackey J.R., Weinfeld M. Senescence evasion by MCF-7 human breast tumor-initiating cells. Breast Cancer Res. 2010, 12:R31.
78. Kawamura T., Suzuki J., Wang Y.V., Menendez S., Morera L.B., Raya A., Wahl G.M., Izpisua Belmonte J.C. Linking the p53 tumour suppressor pathway to somatic cell reprogramming. Nature 2009, 460:1140-1144.
79. Kharas M.G., Yusuf I., Scarfone V.M., Yang V.W., Segre J.A., Huettner C.S., Fruman D.A. KLF4 suppresses transformation of pre-B cells by ABL oncogenes. Blood 2007, 109:747-755.
80. Kim D., Kim C.H., Moon J.I., Chung Y.G., Chang M.Y., Han B.S., Ko S., Yang E., Cha K.Y., Lanza R., Kim K.S. Generation of human induced pluripotent stem cells by direct delivery of reprogramming proteins. Cell Stem Cell 2009, 4:472-476.
81. Kim J.B., Greber B., Arauzo-Bravo M.J., Meyer J., Park K.I., Zaehres H., Scholer H.R. Direct reprogramming of human neural stem cells by OCT4. Nature 2009, 461:649-653.
82. Kochhar R., Howard E.M., Umbreit J.N., Lau S.K. Metaplastic breast carcinoma with squamous differentiation: molecular and clinical analysis of six cases. Breast J. 2005, 11:367-369.
83. Kumar M.S., Erkeland S.J., Pester R.E., Chen C.Y., Ebert M.S., Sharp P.A., Jacks T. Suppression of non-small cell lung tumor development by the let-7 microRNA family. Proc. Natl. Acad. Sci. U.S.A. 2008, 105:3903-3908.
84. Lafontan M. Advances in adipose tissue metabolism. Int. J. Obes. (Lond) 2008, 32(Suppl. 7):S39-S51.
85. Lee Y., Jung J., Cho K.J., Lee S.K., Park J.W., Oh I.H., Kim G.J. Increased SCF/c-kit by hypoxia promotes autophagy of human placental chorionic plate-derived mesenchymal stem cells via regulating the phosphorylation of mTOR. J. Cell. Biochem. 2013, 114:79-88.
86. Lefebvre V., Dumitriu B., Penzo-Mendez A., Han Y., Pallavi B. Control of cell fate and differentiation by Sry-related high-mobility-group box (Sox) transcription factors. Int. J. Biochem. Cell Biol. 2007, 39:2195-2214.
87. Lengerke C., Fehm T., Kurth R., Neubauer H., Scheble V., Muller F., Schneider F., Petersen K., Wallwiener D., Kanz L., Fend F., Perner S., Bareiss P.M., Staebler A. Expression of the embryonic stem cell marker SOX2 in early-stage breast carcinoma. BMC Cancer 2011, 11:42.
88. Li H., Collado M., Villasante A., Strati K., Ortega S., Canamero M., Blasco M.A., Serrano M. The Ink4/Arf locus is a barrier for iPS cell reprogramming. Nature 2009, 460:1136-1139.
89. Li W., Zhou H., Abujarour R., Zhu S., Young Joo J., Lin T., Hao E., Schöler H.R., Hayek A., Ding S. Generation of human-induced pluripotent stem cells in the absence of exogenous Sox2. Stem Cells 2009, 27:2992-3000. 10.1002/stem.240.
90. Liu Y., Clem B., Zuba-Surma E.K., El-Naggar S., Telang S., Jenson A.B., Wang Y., Shao H., Ratajczak M.Z., Chesney J., Dean D.C. Mouse fibroblasts lacking RB1 function form spheres and undergo reprogramming to a cancer stem cell phenotype. Cell Stem Cell 2009, 4:336-347.
91. Liu F., Lee J.Y., Wei H., Tanabe O., Engel J.D., Morrison S.J., Guan J.L. FIP200 is required for the cell-autonomous maintenance of fetal hematopoietic stem cells. Blood 2010, 116:4806-4814.
92. Maddika S., Ande S.R., Panigrahi S., Paranjothy T., Weglarczyk K., Zuse A., Eshraghi M., Manda K.D., Wiechec E., Los M. Cell survival, cell death and cell cycle pathways are interconnected: implications for cancer therapy. Drug Resist. Updat. 2007, 10:13-29.
93. Marchetto M.C., Carromeu C., Acab A., Yu D., Yeo G.W., Mu Y., Chen G., Gage F.H., Muotri A.R. A model for neural development and treatment of Rett syndrome using human induced pluripotent stem cells. Cell 2010, 143:527-539.
94. Marion R.M., Strati K., Li H., Murga M., Blanco R., Ortega S., Fernandez-Capetillo O., Serrano M., Blasco M.A. A p53-mediated DNA damage response limits reprogramming to ensure iPS cell genomic integrity. Nature 2009, 460:1149-1153.
95. Matsuoka J., Yashiro M., Sakurai K., Kubo N., Tanaka H., Muguruma K., Sawada T., Ohira M., Hirakawa K. Role of the stemness factors sox2, oct3/4, and nanog in gastric carcinoma. J. Surg. Res. 2012, 174:130-135.
96. Matsuura T., Hosokawa R., Okamoto K., Kimoto T., Akagawa Y. Diverse mechanisms of osteoblast spreading on hydroxyappatit and titanium. Biomaterials 2000, 21:1121-1127.
97. Menendez S., Camus S., Izpisua Belmonte J.C., Menendez S., Camus S., Izpisua Belmonte J.C. p53: guardian of reprogramming. Cell cycle (Georgetown, Tex.) 2010, 9:3887-3891.
98. Menendez J.A., Vellon L., Oliveras-Ferraros C., Cufi S., Vazquez-Martin A. mTOR-regulated senescence and autophagy during reprogramming of somatic cells to pluripotency: a roadmap from energy metabolism to stem cell renewal and aging. Cell cycle (Georgetown, Tex.) 2011, 10:3658-3677.
99. Mikkelsen T.S., Hanna J., Zhang X., Ku M., Wernig M., Schorderet P., Bernstein B.E., Jaenisch R., Lander E.S., Meissner A. Dissecting direct reprogramming through integrative genomic analysis. Nature 2008, 454:49-55.
100. Miller L.D., Smeds J., George J., Vega V.B., Vergara L., Ploner A., Pawitan Y., Hall P., Klaar S., Liu E.T., Bergh J. An expression signature for p53 status in human breast cancer predicts mutation status, transcriptional effects, and patient survival. Proc. Natl. Acad. Sci. U.S.A. 2005, 102:13550-13555.
101. Miura K., Okada Y., Aoi T., Okada A., Takahashi K., Okita K., Nakagawa M., Koyanagi M., Tanabe K., Ohnuki M., Ogawa D., Ikeda E., Okano H., Yamanaka S. Variation in the safety of induced pluripotent stem cell lines. Nat. Biotechnol. 2009, 27:743-745.
102. Mizuno H., Spike B.T., Wahl G.M., Levine A.J. Inactivation of p53 in breast cancers correlates with stem cell transcriptional signatures. Proc. Natl. Acad. Sci. U.S.A. 2010, 107:22745-22750.
103. Moawad A.R., Choi I., Zhu J., Campbell K.H. Ovine oocytes vitrified at germinal vesicle stage as cytoplast recipients for somatic cell nuclear transfer (SCNT). Cell Reprogram. 2011, 13:289-296.
104. Momcilovic O., Knobloch L., Fornsaglio J., Varum S., Easley C., Schatten G. DNA damage responses in human induced pluripotent stem cells and embryonic stem cells. PLoS One 2010, 5:e13410.
105. Mortensen M., Soilleux E.J., Djordjevic G., Tripp R., Lutteropp M., Sadighi-Akha E., Stranks A.J., Glanville J., Knight S., Jacobsen S.E., Kranc K.R., Simon A.K. The autophagy protein Atg7 is essential for hematopoietic stem cell maintenance. J. Exp. Med. 2011, 208:455-467.
106. Nadiminty N., Tummala R., Lou W., Zhu Y., Shi X.B., Zou J.X., Chen H., Zhang J., Chen X., Luo J., deVere White R.W., Kung H.J., Evans C.P., Gao A.C. MicroRNA let-7c is downregulated in prostate cancer and suppresses prostate cancer growth. PLoS One 2012, 7:e32832.
107. Nagata T., Shimada Y., Sekine S., Hori R., Matsui K., Okumura T., Sawada S., Fukuoka J., Tsukada K. Prognostic significance of NANOG and KLF4 for breast cancer. Breast Cancer 2012, [Epub ahead of print].
108. Nakagawa M., Koyanagi M., Tanabe K., Takahashi K., Ichisaka T., Aoi T., Okita K., Mochiduki Y., Takizawa N., Yamanaka S. Generation of induced pluripotent stem cells without Myc from mouse and human fibroblasts. Nat. Biotechnol. 2008, 26:101-106.
109. Nakagawa M., Takizawa N., Narita M., Ichisaka T., Yamanaka S. Promotion of direct reprogramming by transformation-deficient Myc. Proc. Natl. Acad. Sci. U.S.A. 2010, 107:14152-14157.
110. Nakatogawa H., Suzuki K., Kamada Y., Ohsumi Y. Dynamics and diversity in autophagy mechanisms: lessons from yeast. Nat. Rev. Mol. Cell Biol. 2009, 10:458-467.
111. Neumann J., Bahr F., Horst D., Kriegl L., Engel J., Luque R.M., Gerhard M., Kirchner T., Jung A. SOX2 expression correlates with lymph-node metastases and distant spread in right-sided colon cancer. BMC Cancer 2011, 11:518.
112. Okita K., Yamanaka S. Induced pluripotent stem cells: opportunities and challenges. Philos. Trans. R. Soc. Lond., B, Biol. Sci. 2011, 366:2198-2207.
113. Okita K., Ichisaka T., Yamanaka S. Generation of germline-competent induced pluripotent stem cells. Nature 2007, 448:313-317.
114. Okita K., Nakagawa M., Hyenjong H., Ichisaka T., Yamanaka S. Generation of mouse induced pluripotent stem cells without viral vectors. Science 2008, 322:949-953.
115. Oliver L., Hue E., Priault M., Vallette F.M. Basal autophagy decreased during the differentiation of human adult mesenchymal stem cells. Stem Cells Dev. 2012, 21:2779-2788.
116. Parry M.C., Bhabra G., Sood A., Machado F., Cartwright L., Saunders M., Ingham E., Newson R., Blom A.W., Case C.P. Thresholds for indirect DNA damage across cellular barriers for orthopaedic biomaterials. Biomaterials 2010, 31:4477-4483.
117. Patel M., Yang S. Advances in reprogramming somatic cells to induced pluripotent stem cells. Stem Cell Rev. 2010, 6:367-380.
118. Peng S., Maihle N.J., Huang Y. Pluripotency factors Lin28 and Oct4 identify a sub-population of stem cell-like cells in ovarian cancer. Oncogene 2010, 29:2153-2159.
119. Place E.S., Evans N.D., Stevens M.M. Complexity in Biomaterials for tissue engineering. Nat. Mater. 2009, 8:457-470.
120. Plews J.R., Li J., Jones M., Moore H.D., Mason C., Andrews P.W., Na J. Activation of pluripotency genes in human fibroblast cells by a novel mRNA based approach. PLoS One 2010, 5:e14397.
121. Prigione A., Fauler B., Lurz R., Lehrach H., Adjaye J. The senescence-related mitochondrial/oxidative stress pathway is repressed in human induced pluripotent stem cells. Stem Cells 2010, 28:721-733.
122. Räisänen L., Könönen M., Juhanoja J., Varpavaara P., Hautaniemi J., Kivilahti J., Hormia M. Expression of cell adhesion complexes in epithelial cells seeded on biomaterial surfaces. J. Biomed. Mater. Res. 2000, 49:79-87.
123. Ravikumar B., Sarkar S., Davies J.E., Futter M., Garcia-Arencibia M., Green-Thompson Z.W., Jimenez-Sanchez M., Korolchuk V.I., Lichtenberg M., Luo S., Massey D.C., Menzies F.M., Moreau K., Narayanan U., Renna M., Siddiqi F.H., Underwood B.R., Winslow A.R., Rubinsztein D.C. Regulation of mammalian autophagy in physiology and pathophysiology. Physiol. Rev. 2010, 90:1383-1435.
124. Reya T., Morrison S.J., Clarke M.F., Weissman I.L. Stem cells, cancer, and cancer stem cells. Nature 2001, 414:105-111.
125. Ribatti D. Cancer stem cells and tumor angiogenesis. Cancer Lett. 2012, 321:13-17.
126. Rius M., Lyko F. Epigenetic cancer therapy: rationales, targets and drugs. Oncogene 2012, 31:4257-4265.
127. Rotter D., Rothermel B.A. Targets, trafficking, and timing of cardiac autophagy. Pharmacol. Res. 2012, 66:494-504.
128. Rowland B.D., Bernards R., Peeper D.S. The KLF4 tumour suppressor is a transcriptional repressor of p53 that acts as a context-dependent oncogene. Nat. Cell Biol. 2005, 7:1074-1082.
129. Rubinsztein D.C., Cuervo A.M., Ravikumar B., Sarkar S., Korolchuk V., Kaushik S., Klionsky D.J. In search of an "autophagomometer". Autophagy 2009, 5:585-589.
130. Ruoslahti E., Pierschbacher M.D. New perspectives in cell adhesion: RGD and integrins. Science 1987, 238:491-497.
131. Sabisz M., Skladanowski A. Cancer stem cells and escape from drug-induced premature senescence in human lung tumor cells: implications for drug resistance and in vitro drug screening models. Cell cycle (Georgetown, Tex.) 2009, 8:3208-3217.
132. Saigusa S., Tanaka K., Toiyama Y., Yokoe T., Okugawa Y., Ioue Y., Miki C., Kusunoki M. Correlation of CD133, OCT4, and SOX2 in rectal cancer and their association with distant recurrence after chemoradiotherapy. Ann. Surg. Oncol. 2009, 16:3488-3498.
133. Salemi S., Yousefi S., Constantinescu M.A., Fey M.F., Simon H.U. Autophagy is required for self-renewal and differentiation of adult human stem cells. Cell Res. 2012, 22:432-435.
134. Sato H., Takahashi M., Ise H., Yamada A., Hirose S.-i., Tagawa Y.-i., Morimoto H., Izawa A., Ikeda U. Collagen synthesis is require for ascorbic acid-enhanced differentiation of mouse embryonic stem cells into cardiomyocytes. Biochem. Biophys. Res. Commun. 2006, 342:107-112.
135. Schenke-Layland K., Rhodes K.E., Angelis E., Butylkova Y., Heydarkhan-Hagvall S., Gekas C., Zhang R., Goldhaber J.I., Mikkola H.K., Plath K., Robb M.W. Reprgrammed mouse fibroblasts differentiate into cells of the cardiovascular and hematopoietic lineages. Stem Cells 2008, 26:1537-1546.
136. Shan J., Shen J., Liu L., Xia F., Xu C., Duan G., Xu Y., Ma Q., Yang Z., Zhang Q., Ma L., Liu J., Xu S., Yan X., Bie P., Cui Y., Bian X.W., Qian C. Nanog regulates self-renewal of cancer stem cell through IGF pathway in human hepatocellular carcinoma. Hepatology 2012, 56:1004-1014.
137. Singh R., Cuervo A.M. Autophagy in the cellular energetic balance. Cell Metab. 2011, 13:495-504.
138. Singh J., Carlisle D.L., Pritchard D.E., Patierno S.R. Chromium-induced genotoxicity and apoptosis: relationship to chromium carcinogenesis (review). Oncol. Rep. 1998, 5:1307-1325.
139. Sommer C.A., Stadtfeld M., Murphy G.J., Hochedlinger K., Kotton D.N., Mostoslavsky G. Induced pluripotent stem cell generation using a single lentiviral stem cell cassette. Stem Cells 2009, 27:543-549.
140. Sridharan R., Tchieu J., Mason M.J., Yachechko R., Kuoy E., Horvath S., Zhou Q., Plath K. Role of the murine reprogramming factors in the induction of pluripotency. Cell 2009, 136:364-377.
141. Stadtfeld M., Hochedlinger K. Induced pluripotency: history, mechanisms, and applications. Genes Dev. 2010, 24:2239-2263.
142. Stolzenburg S., Rots M.G., Beltran A.S., Rivenbark A.G., Yuan X., Qian H., Strahl B.D., Blancafort P. Targeted silencing of the oncogenic transcription factor SOX2 in breast cancer. Nucleic Acids Res. 2012, 40:6725-6740.
143. Suhr S.T., Chang E.A., Tjong J., Alcasid N., Perkins G.A., Goissis M.D., Ellisman M.H., Perez G.I., Cibelli J.B. Mitochondrial rejuvenation after induced pluripotency. PLoS One 2010, 5:e14095.
144. Suo G., Han J., Wang X., Zhang J., Zhao Y., Dai J. Oct4 pseudogenes are transcribed in cancers. Biochem. Biophys. Res. Commun. 2005, 337:1047-1051.
145. Takahashi K., Yamanaka S. Induction of pluripotent stem cells from mouse embryonic and adult fibroblast cultures by defined factors. Cell 2006, 126:663-676.
146. Tirino V., Desiderio V., d'Aquino R., De Francesco F., Pirozzi G., Graziano A., Galderisi U., Cavaliere C., De Rosa A., Papaccio G., Giordano A. Detection and characterization of CD133+ cancer stem cells in human solid tumours. PLoS One 2008, 3:e3469.
147. Tsai L.L., Yu C.C., Chang Y.C., Yu C.H., Chou M.Y. Markedly increased Oct4 and Nanog expression correlates with cisplatin resistance in oral squamous cell carcinoma. J. Oral Pathol. Med. 2011, 40:621-628.
148. Tsaousi A., Jones E., Case C.P. The in vitro genotoxicity of orthopaedic ceramic (Al2O3) and metal (CoCr alloy) particles. Mutat. Res. 2010, 697:1-9.
149. Uchino K., Hirano G., Hirahashi M., Isobe T., Shirakawa T., Kusaba H., Baba E., Tsuneyoshi M., Akashi K. Human Nanog pseudogene8 promotes the proliferation of gastrointestinal cancer cells. Exp. Cell Res. 2012, 318:1799-1807.
150. Vafa O., Wade M., Kern S., Beeche M., Pandita T.K., Hampton G.M., Wahl G.M. c-Myc can induce DNA damage, increase reactive oxygen species, and mitigate p53 function: a mechanism for oncogene-induced genetic instability. Mol. Cell 2002, 9:1031-1044.
151. van den Berg A., Mols J., Han J. RISC-target interaction: cleavage and translational suppression. Biochim. Biophys. Acta 2008, 1779:668-677.
152. van Tuyn J., Pijnappels D.A., de Vries A.A., de Vries I., van der Velde-van Dijke I., Knaan-Shanzer S., van der Laarse A., Schalij M.J., Atsma D.E. Fibroblasts from human postmyocardial infarction scars acquire properties of cardiomyocytes after transduction with a recombinant myocardin gene. FASEB J. 2007, 21:3369-3379.
153. Vazquez P., Arroba A.I., Cecconi F., de la Rosa E.J., Boya P., de Pablo F. Atg5 and Ambra1 differentially modulate neurogenesis in neural stem cells. Autophagy 2012, 8:187-199.
154. Vessoni A.T., Muotri A.R., Okamoto O.K. Autophagy in stem cell maintenance and differentiation. Stem Cells Dev. 2012, 21:513-520.
155. Vierbuchen T., Ostermeier A., Pang Z.P., Kokubu Y., Sudhof T.C., Wernig M. Direct conversion of fibroblasts to functional neurons by defined factors. Nature 2010, 463:1035-1041.
156. Vincent F.C., Los M.J. New potential instrument to fight hepatocellular cancer by restoring p53. Hepat. Mon. 2011, 11:331-332.
157. Viswanathan S.R., Daley G.Q., Gregory R.I. Selective blockade of microRNA processing by Lin28. Science 2008, 320:97-100.
158. Viswanathan S.R., Powers J.T., Einhorn W., Hoshida Y., Ng T.L., Toffanin S., O'Sullivan M., Lu J., Phillips L.A., Lockhart V.L., Shah S.P., Tanwar P.S., Mermel C.H., Beroukhim R., Azam M., Teixeira J., Meyerson M., Hughes T.P., Llovet J.M., Radich J., Mullighan C.G., Golub T.R., Sorensen P.H., Daley G.Q. Lin28 promotes transformation and is associated with advanced human malignancies. Nat. Genet. 2009, 41:843-848.
159. Wang X., Liang Y., Chen Q., Xu H.M., Ge N., Luo R.Z., Shao J.Y., He Z., Zeng Y.X., Kang T., Yun J.P., Xie F. Prognostic significance of SOX2 expression in nasopharyngeal carcinoma. Cancer Invest. 2012, 30:79-85.
160. Warren L., Manos P.D., Ahfeldt T., Loh Y.H., Li H., Lau F., Ebina W., Mandal P.K., Smith Z.D., Meissner A., Daley G.Q., Brack A.S., Collins J.J., Cowan C., Schlaeger T.M., Rossi D.J. Highly efficient reprogramming to pluripotency and directed differentiation of human cells with synthetic modified mRNA. Cell Stem Cell 2010, 7:618-630.
161. Wary K.K., Mainiero F., Isakoff S.J., Marcantonio E.E., Giancotti F.G. The adaptor protein Shc couples a class of integrins to the control of cell cycle progression. Cell 1996, 87:733-743.
162. Wernig M., Meissner A., Cassady J.P., Jaenisch R. c-Myc is dispensable for direct reprogramming of mouse fibroblasts. Cell Stem Cell 2008, 2:10-12.
163. West J.A., Viswanathan S.R., Yabuuchi A., Cunniff K., Takeuchi A., Park I.H., Sero J.E., Zhu H., Perez-Atayde A., Frazier A.L., Surani M.A., Daley G.Q. A role for Lin28 in primordial germ-cell development and germ-cell malignancy. Nature 2009, 460:909-913.
164. Wiechec E. Implications of genomic instability in the diagnosis and treatment of breast cancer. Expert Rev. Mol. Diagn. 2011, 11:445-453.
165. Wiechec E., Overgaard J., Kjeldsen E., Hansen L.L. Chromosome 1q25.3 copy number alterations in primary breast cancers detected by multiplex ligation-dependent probe amplification and allelic imbalance assays and its comparison with fluorescent in situ hybridization assays. Cell. Oncol. (Dordr.) 2013, 36:113-120.
166. Wilmut I., Schnieke A.E., McWhir J., Kind A.J., Campbell K.H. Viable offspring derived from fetal and adult mammalian cells. Nature 1997, 385:810-813.
167. Woltjen K., Michael I.P., Mohseni P., Desai R., Mileikovsky M., Hamalainen R., Cowling R., Wang W., Liu P., Gertsenstein M., Kaji K., Sung H.K., Nagy A. piggyBac transposition reprograms fibroblasts to induced pluripotent stem cells. Nature 2009, 458:766-770.
168. Wu Y.T., Tan H.L., Shui G., Bauvy C., Huang Q., Wenk M.R., Ong C.N., Codogno P., Shen H.M. Dual role of 3-methyladenine in modulation of autophagy via different temporal patterns of inhibition on class I and III phosphoinositide 3-kinase. J. Biol. Chem. 2010, 285:10850-10861.
169. Xynos I.D., Edgar A.J., Buttery L.D.K., Hench L., Polak J.M. Gene-expression profiling of human osteoblasts following treatment with the ionic products of Bioglass 45S5 dissolution. J. Biomed. Mater. Res. 2000, 55:151-157.
170. Yamanaka S. A fresh look at iPS cells. Cell 2009, 137:13-17.
171. Yang S., Zheng J., Ma Y., Zhu H., Xu T., Dong K., Xiao X. Oct4 and Sox2 are overexpressed in human neuroblastoma and inhibited by chemotherapy. Oncol. Rep. 2012, 28:186-192.
172. Yoshida Y., Takahashi K., Okita K., Ichisaka T., Yamanaka S. Hypoxia enhances the generation of induced pluripotent stem cells. Cell Stem Cell 2009, 5:237-241.
173. Yoshimori T. Autophagy as a bulk protein degradation system: it plays various roles. Tanpakushitsu kakusan koso 2004, 49:1029-1032.
174. Yu J., Hu K., Smuga-Otto K., Tian S., Stewart R., Slukvin I.I., Thomson J.A. Human induced pluripotent stem cells free of vector and transgene sequences. Science 2009, 324:797-801.
175. Zbinden M., Duquet A., Lorente-Trigos A., Ngwabyt S.N., Borges I., Ruiz i Altaba A. NANOG regulates glioma stem cells and is essential in vivo acting in a cross-functional network with GLI1 and p53. EMBO J. 2010, 29:2659-2674.
176. Zhang W., Geiman D.E., Shields J.M., Dang D.T., Mahatan C.S., Kaestner K.H., Biggs J.R., Kraft A.S., Yang V.W. The gut-enriched Kruppel-like factor (Kruppel-like factor 4) mediates the transactivating effect of p53 on the p21WAF1/Cip1 promoter. J. Biol. Chem. 2000, 275:18391-18398.
177. Zhang J., Wang X., Li M., Han J., Chen B., Wang B., Dai J. NANOGP8 is a retrogene expressed in cancers. FEBS J. 2006, 273:1723-1730.
178. Zhang M., Behbod F., Atkinson R.L., Landis M.D., Kittrell F., Edwards D., Medina D., Tsimelzon A., Hilsenbeck S., Green J.E., Michalowska A.M., Rosen J.M. Identification of tumor-initiating cells in a p53-null mouse model of breast cancer. Cancer Res. 2008, 68:4674-4682.
179. Zhang N., Zhang J., Shuai L., Zha L., He M., Huang Z., Wang Z. Kruppel-like factor 4 negatively regulates beta-catenin expression and inhibits the proliferation, invasion and metastasis of gastric cancer. Int. J. Oncol. 2012, 40:2038-2048.
180. Zhang Q., Yang Y.J., Wang H., Dong Q.T., Wang T.J., Qian H.Y., Xu H. Autophagy activation: a novel mechanism of atorvastatin to protect mesenchymal stem cells from hypoxia and serum deprivation via AMP-activated protein kinase/mammalian target of rapamycin pathway. Stem Cells Dev. 2012, 21:1321-1332.
181. Zhao M., An M., Wang Q., Liu X., Lai W., Zhao X., Wei S., Ji J. Quantitative proteomic analysis of human osteoblast-like MG-63 cells in response to bioinert implant material titanium and polyetheretherketone. J. Proteome 2012, 75:3560-3573.
182. Zheng H., Ying H., Yan H., Kimmelman A.C., Hiller D.J., Chen A.J., Perry S.R., Tonon G., Chu G.C., Ding Z., Stommel J.M., Dunn K.L., Wiedemeyer R., You M.J., Brennan C., Wang Y.A., Ligon K.L., Wong W.H., Chin L., DePinho R.A. p53 and Pten control neural and glioma stem/progenitor cell renewal and differentiation. Nature 2008, 455:1129-1133.
183. Zhou L., Wei X., Cheng L., Tian J., Jiang J.J. CD133, one of the markers of cancer stem cells in Hep-2 cell line. Laryngoscope 2007, 117:455-460.
184. Zreiqat H., Valenzuela S.M., Nissan B.B., Roecst R., Knabe C., Radlanski R.J., Renz H., Evans P.J. The effect of surface chemistry modification of titanium alloy on signalling pathways in human osteoblasts. Biomaterials 2005, 26:7579-7586.